165 related articles for article (PubMed ID: 28866666)
61. Clinical phenotypic characteristics in patients carrying MYH7-R143Q mutation with hypertrophic cardiomyopathy.
Zhang L; Zhang Y; Wang J; Ta S; Zhao J; Yao L; Han C; Liu J; Zhao X; Yuan J; Li R; Shan B; Wang Y; Qin Y; Wang B; Liu L
Curr Probl Cardiol; 2024 Jan; 49(1 Pt C):102164. PubMed ID: 37907184
[TBL] [Abstract][Full Text] [Related]
62. The association between brain natriuretic peptide and tissue Doppler parameters in children with hypertrophic cardiomyopathy.
Öner T; Özdemir R; Hazan F; Karadeniz C; Doksoz Ö; Yilmazer MM; Meşe T; Tavli V
Bosn J Basic Med Sci; 2016 Jan; 16(1):58-63. PubMed ID: 26773184
[TBL] [Abstract][Full Text] [Related]
63. [Comparative study of gene mutation between Chinese patients with familial and sporadic hypertrophic cardiomyopathy].
Pan GZ; Liu WL; Hu DY; Xie WL; Zhu TG; Li L; Li CL; Bian H
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2998-3001. PubMed ID: 17288815
[TBL] [Abstract][Full Text] [Related]
64. Mutations in the sarcomere gene MYH7 in Ebstein anomaly.
Postma AV; van Engelen K; van de Meerakker J; Rahman T; Probst S; Baars MJ; Bauer U; Pickardt T; Sperling SR; Berger F; Moorman AF; Mulder BJ; Thierfelder L; Keavney B; Goodship J; Klaassen S
Circ Cardiovasc Genet; 2011 Feb; 4(1):43-50. PubMed ID: 21127202
[TBL] [Abstract][Full Text] [Related]
65. Biallelic mutation in MYH7 and MYBPC3 leads to severe cardiomyopathy with left ventricular noncompaction phenotype.
Kolokotronis K; Kühnisch J; Klopocki E; Dartsch J; Rost S; Huculak C; Mearini G; Störk S; Carrier L; Klaassen S; Gerull B
Hum Mutat; 2019 Aug; 40(8):1101-1114. PubMed ID: 30924982
[TBL] [Abstract][Full Text] [Related]
66. Somatic MYH7, MYBPC3, TPM1, TNNT2 and TNNI3 mutations in sporadic hypertrophic cardiomyopathy.
Núñez L; Gimeno-Blanes JR; Rodríguez-García MI; Monserrat L; Zorio E; Coats C; McGregor CG; Hernandez del Rincón JP; Castro-Beiras A; Hermida-Prieto M
Circ J; 2013; 77(9):2358-65. PubMed ID: 23782526
[TBL] [Abstract][Full Text] [Related]
67. Next-generation sequencing identifies pathogenic and modifier mutations in a consanguineous Chinese family with hypertrophic cardiomyopathy.
Zhang X; Xie J; Zhu S; Chen Y; Wang L; Xu B
Medicine (Baltimore); 2017 Jun; 96(24):e7010. PubMed ID: 28614222
[TBL] [Abstract][Full Text] [Related]
68. Worse prognosis with gene mutations of beta-myosin heavy chain than myosin-binding protein C in Chinese patients with hypertrophic cardiomyopathy.
Wang S; Zou Y; Fu C; Xu X; Wang J; Song L; Wang H; Chen J; Wang J; Huan T; Hui R
Clin Cardiol; 2008 Mar; 31(3):114-8. PubMed ID: 18383048
[TBL] [Abstract][Full Text] [Related]
69. Diastolic dysfunction without left ventricular hypertrophy is an early finding in children with hypertrophic cardiomyopathy-causing mutations in the beta-myosin heavy chain, alpha-tropomyosin, and myosin-binding protein C genes.
Poutanen T; Tikanoja T; Jääskeläinen P; Jokinen E; Silvast A; Laakso M; Kuusisto J
Am Heart J; 2006 Mar; 151(3):725.e1-725.e9. PubMed ID: 16504640
[TBL] [Abstract][Full Text] [Related]
70. Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting.
Santos S; Lança V; Oliveira H; Branco P; Silveira L; Marques V; Brito D; Madeira H; Bicho M; Fernandes AR
Rev Port Cardiol; 2011 Jan; 30(1):7-18. PubMed ID: 21425739
[TBL] [Abstract][Full Text] [Related]
71. Whole Exome Sequencing Identified a 13 Base Pair
Fan LL; Guo S; Jin JY; He ZJ; Zhao SP; Xiang R; Zhao W
Ann Clin Lab Sci; 2019 Nov; 49(6):838-840. PubMed ID: 31882438
[No Abstract] [Full Text] [Related]
72. [The pathogenic gene screening in a cardiomyopathy pedigree of Yunnan province].
Xiang H; Zhang J; Hao YL; Fan J; Li FY; Wang LL; Ding LQ; Zhang X; Kuang XH; Gao XL
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 May; 44(5):416-20. PubMed ID: 27220577
[TBL] [Abstract][Full Text] [Related]
73. The effects of candesartan on left ventricular hypertrophy and function in nonobstructive hypertrophic cardiomyopathy: a pilot, randomized study.
Penicka M; Gregor P; Kerekes R; Marek D; Curila K; Krupicka J;
J Mol Diagn; 2009 Jan; 11(1):35-41. PubMed ID: 19074594
[TBL] [Abstract][Full Text] [Related]
74. Abnormal blood pressure response to exercise occurs more frequently in hypertrophic cardiomyopathy patients with the R92W troponin T mutation than in those with myosin mutations.
Heradien M; Revera M; van der Merwe L; Goosen A; Corfield VA; Brink PA; Mayosi BM; Moolman-Smook JC
Heart Rhythm; 2009 Nov; 6(11 Suppl):S18-24. PubMed ID: 19880069
[TBL] [Abstract][Full Text] [Related]
75. Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutations.
Witjas-Paalberends ER; Güçlü A; Germans T; Knaapen P; Harms HJ; Vermeer AM; Christiaans I; Wilde AA; Dos Remedios C; Lammertsma AA; van Rossum AC; Stienen GJ; van Slegtenhorst M; Schinkel AF; Michels M; Ho CY; Poggesi C; van der Velden J
Cardiovasc Res; 2014 Jul; 103(2):248-57. PubMed ID: 24835277
[TBL] [Abstract][Full Text] [Related]
76. The electrocardiogram is a more sensitive indicator than echocardiography of hypertrophic cardiomyopathy in families with a mutation in the MYH7 gene.
al-Mahdawi S; Chamberlain S; Chojnowska L; Michalak E; Nihoyannopoulos P; Ryan M; Kusnierczyk B; French JA; Gilligan DM; Cleland J
Br Heart J; 1994 Aug; 72(2):105-11. PubMed ID: 7848420
[TBL] [Abstract][Full Text] [Related]
77. Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: a comparison between cardiac magnetic resonance imaging and echocardiography.
Corona-Villalobos CP; Sorensen LL; Pozios I; Chu L; Eng J; Abraham MR; Abraham TP; Kamel IR; Zimmerman SL
Int J Cardiovasc Imaging; 2016 Jun; 32(6):945-54. PubMed ID: 26896038
[TBL] [Abstract][Full Text] [Related]
78. Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy.
Chida A; Inai K; Sato H; Shimada E; Nishizawa T; Shimada M; Furutani M; Furutani Y; Kawamura Y; Sugimoto M; Ishihara J; Fujiwara M; Soga T; Kawana M; Fuji S; Tateno S; Kuraishi K; Kogaki S; Nishimura M; Ayusawa M; Ichida F; Yamazawa H; Matsuoka R; Nonoyama S; Nakanishi T
Heart Vessels; 2017 Jun; 32(6):700-707. PubMed ID: 27885498
[TBL] [Abstract][Full Text] [Related]
79. Genes frequently associated with sudden death in primary hypertrophic cardiomyopathy.
Herrera-Rodríguez DL; Totomoch-Serra A; Rosas-Madrigal S; Luna-Limón C; Marroquín-Ramírez D; Carnevale A; Rosendo-Gutiérrez R; Villarreal-Molina MT; Márquez-Murillo MF
Arch Cardiol Mex; 2020; 90(1):58-68. PubMed ID: 31996869
[TBL] [Abstract][Full Text] [Related]
80. Novel phenotype-genotype correlations of hypertrophic cardiomyopathy caused by mutation in α-actin and myosin-binding protein genes in three unrelated Chinese families.
Yang QL; Bian YY; Wang B; Zuo L; Zhou MY; Shao H; Zhang YM; Liu LW
J Cardiol; 2019 May; 73(5):438-444. PubMed ID: 30600190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
